Trials / Completed
CompletedNCT02032771
Impact of M22 Synergistic Sequential Treatment (SST)
Impact of M22 Synergistic Sequential Treatment (SST) Using Intense Pulsed Light and Fractional Non-ablative Photothermolysis on Skin Texture
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Lumenis Be Ltd. · Industry
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Up to 40 healthy subjects at 2 sites, age 30-65 year old with Fitzpatrick-Elastosis score of 3-6 and mild to moderate age/sun-related facial pigmentation that wish to improve their facial skin appearance. Hypothesis: The SST will improve the appearance of the wrinkles/elastosis and/or pigmentation by at least 1 on the FES scale or ≥50% in category scale at 3 months follow-ups in at least 50% of the study population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | M22 IPL and ResurFX | The procedure will include an intense pulse light (M22 IPL) treatment followed by fractional non-ablative (M22 ResurFX) treatment. |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2014-01-10
- Last updated
- 2016-09-16
Locations
2 sites across 2 countries: United States, Germany
Source: ClinicalTrials.gov record NCT02032771. Inclusion in this directory is not an endorsement.